UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 677

Sortiert nach

Is Inhaled Therapy Better Than IV? Challenges of PVOD

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S537-S537

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthetic routes to treprostinil N-acyl methylsulfonamide

Tetrahedron letters, 2020-01, Vol.61 (5), p.151428, Article 151428

2020

Link zum Volltext

Verfügbarkeit prüfen

Pulmonale Hypertonie bei Lungenerkrankungen

Herz, 2023-08, Vol.48 (4), p.274-279

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder

Pharmaceutics, 2023-03, Vol.15 (3), p.934

2023

Link zum Volltext

Verfügbarkeit prüfen

High-Throughput Genomics Identify Novel IFBN1/2/I Variants in Severe Neonatal Marfan Syndrome and Congenital Heart Defects

International journal of molecular sciences, 2024-05, Vol.25 (10)

2024

Link zum Volltext

Verfügbarkeit prüfen

A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis

Rheumatology (Oxford, England), 2022-05, Vol.61 (6), p.2441-2449

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia–reperfusion injury

Clinica chimica acta, 2024-07, Vol.561, p.119837, Article 119837

2024

Link zum Volltext

Verfügbarkeit prüfen

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

American journal of respiratory and critical care medicine, 2020-03, Vol.201 (6), p.707-717

2020

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary artery hypertension-associated with human immunodeficiency virus infection with attenuated effect of subcutaneous treprostinil injection during long-term observation: A case report

Journal of cardiology cases, 2023-08, Vol.28 (2), p.72-74

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Multiple-Dose Study

Advances in therapy, 2022-11, Vol.39 (11), p.5144-5157

2022

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic Parameters in Predicting Survival in Pulmonary Arterial Hypertension

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S188-S188

2021

Link zum Volltext

Verfügbarkeit prüfen

Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPAR[gamma]-mediated downregulation of TRPC

International journal of molecular medicine, 2022-02, Vol.49 (2), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration

Frontiers in pediatrics, 2023-08, Vol.11, p.1275389-1275389

2023

Link zum Volltext

Verfügbarkeit prüfen

Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series

American journal of health-system pharmacy, 2018-12, Vol.75 (23), p.1877-1881

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeted treprostinil delivery inhibits pulmonary arterial remodeling

European journal of pharmacology, 2022-05, Vol.923, p.174700-174700, Article 174700

2022

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients

Clinical transplantation, 2021-06, Vol.35 (6), p.e14298-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Safe and successful transition from oral selexipag to subcutaneous treprostinil in a patient with idiopathic pulmonary arterial hypertension treated with triple combination therapy

Journal of cardiology cases, 2022-07, Vol.26 (1), p.42-45

2022

Link zum Volltext

Verfügbarkeit prüfen

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV

The Journal of heart and lung transplantation, 2022-11, Vol.41 (11), p.1572-1580

2022

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary hypertension inhaled therapies: An updated review

The American journal of the medical sciences, 2023-07, Vol.366 (1), p.3-15

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial

Circulation (New York, N.Y.), 2013-02, Vol.127 (5), p.624-633

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry

Pulmonary pharmacology & therapeutics, 2023-10, Vol.82, p.102232-102232, Article 102232

2023

Link zum Volltext

Verfügbarkeit prüfen

Continuous Prostanoid Initiation in Severe Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit

Pediatric cardiology, 2023-09

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel developments in the study of estrogen in the pathogenesis and therapeutic intervention of lymphangioleiomyomatosis

Orphanet journal of rare diseases, 2024-06, Vol.19 (1), p.236-7, Article 236

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension

Annals of Thoracic and Cardiovascular Surgery, 2020, pp.oa.20-00003

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 677

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(382)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Treprostinil
(618)
Science & Technology
(334)
Life Sciences & Biomedicine
(331)
Pulmonary Hypertension
(293)
Humans
(192)
Pulmonary Arterial Hypertension
(159)
Epoprostenol - Analogs & Derivatives
(146)
Hypertension, Pulmonary - Drug Therapy
(121)
Cardiovascular System & Cardiology
(118)
Pharmaceutical Industry
(115)
Cardiac & Cardiovascular Systems
(108)
Female
(106)
Male
(103)
Respiratory System
(103)
Epoprostenol
(100)
Pharmacology & Pharmacy
(98)
Epoprostenol - Administration & Dosage
(95)
Prostacyclin
(92)
Antihypertensive Agents - Administration & Dosage
(82)
Forecasts And Trends
(78)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Is Inhaled Therapy Better Than IV? Challenges of PVOD

Synthetic routes to treprostinil N-acyl methylsulfonamide

Pulmonale Hypertonie bei Lungenerkrankungen

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

High-Throughput Genomics Identify Novel IFBN1/2/I Variants in Severe Neonatal Marfan Syndrome and Congenital Heart Defects

A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis

Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia–reperfusion injury

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

Pulmonary artery hypertension-associated with human immunodeficiency virus infection with attenuated effect of subcutaneous treprostinil injection during long-term observation: A case report

Safety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Multiple-Dose Study

Hemodynamic Parameters in Predicting Survival in Pulmonary Arterial Hypertension

Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPAR[gamma]-mediated downregulation of TRPC

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration

Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series

Targeted treprostinil delivery inhibits pulmonary arterial remodeling

An evaluation of the safety and preliminary efficacy of peri‐ and post‐operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients

Safe and successful transition from oral selexipag to subcutaneous treprostinil in a patient with idiopathic pulmonary arterial hypertension treated with triple combination therapy

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV

Pulmonary hypertension inhaled therapies: An updated review

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial

Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry

Continuous Prostanoid Initiation in Severe Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit

Novel developments in the study of estrogen in the pathogenesis and therapeutic intervention of lymphangioleiomyomatosis

Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension

Suchergebnisse filtern